These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. [Strategy and core technologies for the secondary development of Chinese patent medicine]. Zhagn BL; Fan XH; Liu Y; Qu HB; Zhang JH; Chegn YY Zhongguo Zhong Yao Za Zhi; 2013 Nov; 38(22):3797-800. PubMed ID: 24558853 [TBL] [Abstract][Full Text] [Related]
27. Patenting EPO analogs: screening vs. predictability. Kelly P Biotechnology (N Y); 1990 Feb; 8(2):112-3. PubMed ID: 1366357 [No Abstract] [Full Text] [Related]
28. Epo, by any other name. Nature; 2007 Sep; 449(7160):259. PubMed ID: 17882170 [No Abstract] [Full Text] [Related]
29. Antibacterial agents: patent highlights January to June 2002. Phillips OA; Matowe WC Curr Opin Investig Drugs; 2002 Dec; 3(12):1701-11. PubMed ID: 12528302 [TBL] [Abstract][Full Text] [Related]
30. Patenting pluripotence: the next battle for stem cell intellectual property. Vrtovec KT; Scott CT Nat Biotechnol; 2008 Apr; 26(4):393-5. PubMed ID: 18392018 [TBL] [Abstract][Full Text] [Related]
31. Reach-through claims for drug target patents: Rx for pharmaceutical policy. Bohrer RA Nat Biotechnol; 2008 Jan; 26(1):55-6. PubMed ID: 18183015 [No Abstract] [Full Text] [Related]
32. AIDS group takes aim at pharmaceutical firm's patents, prices. AIDS Policy Law; 2002 Jul; 17(13):4. PubMed ID: 12162289 [No Abstract] [Full Text] [Related]
33. Patents and the research exemption. Resnik DB Science; 2003 Feb; 299(5608):821-2. PubMed ID: 12574602 [No Abstract] [Full Text] [Related]
34. Patentability in the United States. Fashena SJ; Jackson DA Nat Rev Drug Discov; 2004 May; 3(5):381. PubMed ID: 15152629 [No Abstract] [Full Text] [Related]
35. Obviousness, hindsight and perspective: the impact of KSR v. Teleflex on biotech and pharmaceutical patents. Teitelbaum R; Cohen M Nat Biotechnol; 2007 Oct; 25(10):1105-6. PubMed ID: 17921990 [No Abstract] [Full Text] [Related]
36. Nurses making a difference: the process of technology transfer. Johnson VY; Walsh EG J Neurosci Nurs; 2005 Oct; 37(5):289-92. PubMed ID: 16379136 [No Abstract] [Full Text] [Related]
37. Prologue: chirality in the pharmaceutical industry. Caldwell J; Berova N; McConnell O Chirality; 2007 Sep; 19(9):657. PubMed ID: 17657706 [No Abstract] [Full Text] [Related]
38. Viewpoint: pharmaceutical innovation in Europe. Baines E Circulation; 2007 Jan; 115(2):f5-6. PubMed ID: 17228009 [No Abstract] [Full Text] [Related]
39. Patents on ice. Stix G Sci Am; 2004 May; 290(5):48. PubMed ID: 15127661 [No Abstract] [Full Text] [Related]